Intravitreal bevacizumab (avastin) for refractory pseudophakic cystoid macular edema

被引:80
作者
Mason, John O., III
Albert, Michael A., Jr.
Vail, Rachel
机构
[1] Retina Consultants Alabama, Birmingham, AL 35233 USA
[2] Univ Alabama, Sch Med, Dept Ophthalmol, Callahan Eye Fdn Hosp, Birmingham, AL USA
来源
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES | 2006年 / 26卷 / 03期
关键词
D O I
10.1097/00006982-200603000-00018
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
[No abstract available]
引用
收藏
页码:356 / 357
页数:2
相关论文
共 5 条
[1]   Intravitreal triamcinolone for refractory pseudophakic macular edema [J].
Benhamou, N ;
Massin, P ;
Haouchine, B ;
Audren, F ;
Tadayoni, R ;
Gaudric, A .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 135 (02) :246-249
[2]  
Flach A J, 1998, Trans Am Ophthalmol Soc, V96, P557
[3]   INCREASED INTRAOCULAR-PRESSURE INDUCED BY REPOSITORY CORTICOSTEROIDS [J].
HERSCHLER, J .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1976, 82 (01) :90-93
[4]   Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema [J].
Jonas, JB ;
Kreissig, I ;
Degenring, RF .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 136 (02) :384-386
[5]   Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin®) for neovascular age-related macular degeneration [J].
Rosenfeld, PJ ;
Moshfeghi, AA ;
Puliafito, CA .
OPHTHALMIC SURGERY LASERS & IMAGING, 2005, 36 (04) :331-335